The Transplantation Society extends its sincere thanks to all members who stood as candidates in the recent election. Your willingness to serve and contribute to the leadership of TTS reflects the strength, commitment, and diversity of our global community. We also thank all members who took the time to vote. Member participation is essential to the Society’s governance and helps ensure that TTS continues to represent the voices and priorities of transplantation professionals worldwide. The newly elected members will begin their terms at the conclusion of the TTS 2026 Congress, taking place in Sydney, Australia, September 20–23, 2026.
Thank you once again to all candidates and voters for your engagement and support of TTS.
Dr. Gabriel E. Gondolesi is an internationally recognized transplant surgeon, scientist, and academic leader. Born in Argentina, he graduated from the National University of La Plata. After completing his residency in General Surgery, he pursued fellowship training in liver transplantation surgery at the Favaloro Foundation in Buenos Aires. In 1999, he continued his training at Mount Sinai Hospital in New York, where he later became Head of Intestinal Transplantation.
In 2006, Dr. Gondolesi returned to Argentina to establish the first comprehensive intestinal failure and transplantation program in Latin America, while expanding the liver and pancreas transplant programs at the Favaloro Foundation. In 2024, he joined the MedStar Georgetown Transplantation Institute, where he introduced innovative approaches including multivisceral and domino liver transplantation, liver split/reduction during normothermic machine perfusion, and the use of DCD+NRP liver and liver–pancreas grafts from pediatric donors.
At The Transplantation Society (TTS) for 25 years, he has served as Latin American Councillor, Treasurer, and Vice-President. He has contributed to global initiatives addressing organ trafficking and transplant tourism through the World Health Organization and the Pontifical Academy of Sciences (2017). He promoted regional collaboration through STALYC (2018) and co-chaired the first TTS conference held in Buenos Aires in 2022. He also served in the International Intestinal Transplant Association (IIRTA) as Councillor, Secretary-Treasurer, and President, establishing 17 international chapters, founding the Intestinal Failure Journal, and strengthening its global identity.
Dr. Gondolesi has trained more than 70 professionals, directed 11 doctoral theses, and authored over 200 manuscripts, 18 book chapters, and the book Transcending. As a candidate for TTS President-Elect, he is committed to strengthening international cooperations to expand donation and transplantation worldwide.

Dr. Martí Manyalich graduated in Medicine from the University of Barcelona in 1977 and specialized in Anesthesiology, Resuscitation, and Pain Medicine. He obtained his PhD with honors and pursued further training in emergency medicine at the University of Paris Val-de-Marne, as well as in business administration at ESADE.
He played a key role in developing a leading emergency care team at Hospital Clínic of Barcelona and contributed to the creation of the Catalan Emergency Medical System. In 1985, as Transplant Coordinator, he increased organ donation rates by 400%.
In 1986, he pioneered uncontrolled donation after circulatory death (DCD), later contributing to advances such as normothermic regional perfusion and ex situ organ perfusion technologies, now applied across multiple organs. Today, donation activity in his region accounts for approximately 62% DCD and 38% DBD.
In 1991, he founded the Transplant Procurement Management (TPM) program, followed by the Transplant Service Foundation (TSF) in 1994, Europe’s first multi-tissue bank. He also contributed to the first university master’s program in donation and transplantation at the University of Barcelona, which has trained over 25,000 professionals from more than 100 countries.
He has led and contributed to several European projects (EQSTB, ETPOD, ODEQUS, EULID, ELIPSY, LIDOBS, EUDONORGAN), improving donation systems, quality, and training.
Dr. Manyalich has authored over 250 publications and held leadership roles including President of ISODP (2015–2017), Councilor of TTS (2018–2026), Chair of the TTS Committee (2020–2022), Vice President of EATB (1999–2003), and President of EDTCO (1997–2001). He has been a member of TTS since 1990.
His work focuses on strengthening global collaboration and expanding access to transplantation worldwide

Alejandro Nino Murcia, M.D., FACS, is a distinguished transplant surgeon at Colombiana de Trasplantes and a revered surgery professor at the Universidad del Rosario in Bogota, Colombia. With a medical degree from the Universidad del Rosario, a General Surgeon certification from the Universidad Militar Nueva Granada, and an honorary transplant surgeon from the University of Minnesota, Dr. Nino-Murcia has dedicated his career to advancing transplantation medicine. Additionally, he has been a fellow of the American College of Surgeons (ACS) since 2002 and holds a Master of Public Health. His public health studies have been and still are crucial for developing laws, helping programs grow and consolidating transplantation not only in Colombia but also in Latin America. In 2017, the Latin American and the Caribbean Transplant Association presented an award in Montevideo, Uruguay praising these efforts.
His leadership roles include serving as President and then Executive Director of the Colombian Transplant Association (ACTO) and as President of the Latin American and the Caribbean Transplant Association (STALYC). Furthermore, he has played pivotal roles in global initiatives, such as being a member of the board for four years and them co-chairing the Declaration of Istanbul Custodian Group (DICG) 2018-2022 and in 2022-2023 honorary member of the board and acting as the vice-chair of the World Transplant Congress TTS 2022 in Buenos Aires. Dr. Nino- Murcia's unwavering commitment to international transplantation and surgical education underscores his profound impact on the field. He was a Latin-American councilor for TTS.
Since 2025 his is the treasurer of the Colombian Academy of Medicine where he is not only a number member but also in the board of directors.

Professor Refaat Kamel, M.B.B.Ch, F.R.C.S., F.I.C.S., M.D., Hon. EBT is a distinguished Egyptian transplant and hepatobiliary surgeon with extensive leadership in liver transplantation, surgical education, and international professional societies. A graduate of Ain Shams University, he completed his residency training at Ain Shams University Hospitals and King’s College Hospital in London. He earned his M.D. in Surgery from Ain Shams University in 1991 and became a Fellow of the Royal College of Surgeons of England and the International College of Surgeons the same year. He is also an Honorary Fellow of the European Board of Transplantation.
Professor Kamel has served as Chair of the Surgical Departments at Ain Shams University, Head of the Hepato-Bilio-Pancreatic Surgery Department, and Director of the National Liver Transplant Program. Since 2001, he has been Chief Liver Transplant Surgeon in three leading liver transplant programs in Egypt, with experience in more than 1,500 living donor liver transplant cases.
He has held numerous leadership roles, including President of the Middle East Society of Organ Transplantation, President of the Egyptian Society of Organ Transplantation, President of the Egyptian Section of the International College of Surgeons, and President and Co-founder of the Egyptian French Medical Association. He also served as a TTS Councilor and contributed to national and international efforts on organ donation law, communication, and the Istanbul Declaration on organ trafficking and transplant tourism.
Professor Kamel has published more than 150 papers in local and international journals and has contributed to international books on living donor liver transplantation.

Dr. Anette Melk (MD PhD) is a Professor of Pediatrics and Transplantation Medicine at Hannover Medical School. She is the director of the DFG-funded Young Academy - PRACTIS (PRogram of hAnnover medical school for Clinician scienTISts).
Dr. Melk received her MD at the University of Giessen (Germany) and her PhD from University of Alberta (Canada). She trained as a Pediatric Nephrologist at the University of Heidelberg Children’s Hospital.
Dr. Melk’s translational work on pathways leading to impaired regeneration in the pathogenesis of renal and cardiovascular diseasesincludes basic findings and concepts from cell and animal models to clinical applications. She has pioneered the idea that cellular senescence is crucial for the insufficient regenerative capacity of donor organs and an important target in therapeutic approaches.
Dr. Melk’s clinical research projects aim to further decipher factors leading to cardiovascular and renal comorbidity in transplant recipients. She initiated the largest longitudinal clinical study assessing cardiovascular health in children and adults after solid organ and stem cell transplantation (4C-T, cardiovascular comorbidity in children with chronic disease and transplantation). Anette’s holistic view on optimization of patient and graft survival lead her build the first German research consortium that deals with sex- and gender-related differences in renal transplantation.
Dr. Melk serves on several national and international boards. She has received numerous awards, one of which is the prestigious Rudolf-Pichlmayr Prize of the German Transplant Society. She has published more than 100 scientific articles and book chapters; her current H-Index is 27.

Dr. Elias David-Neto is a distinguished Brazilian nephrologist and transplant physician. Born in São Paulo on April 24, 1955, he graduated from the Faculdade de Ciências Médicas de Santos in 1978 and completed his training in internal medicine and nephrology at Hospital das Clínicas, Faculty of Medicine, University of São Paulo (HC-FMUSP). He earned his doctorate in 1989 and his habilitation in 2000, and since 2015 has served as Full Professor in the Department of Internal Medicine at the Faculdade de Medicina de Jundiaí.
Dr. David-Neto has been a member of the Renal Transplant Service at HC-FMUSP since 1982 and became its Director in 2018. Under his leadership, the program expanded transplant activity and advanced key innovations including pediatric kidney transplantation, paired kidney donation, and ABO-incompatible transplantation. He also helped establish major clinical and research infrastructure in transplantation, including electronic medical records, clinical research programs, immunosuppressive drug monitoring, and diagnostic techniques for antibody-mediated rejection.
He has trained numerous graduate students and physician leaders in Brazil and abroad. Dr. David-Neto served as President of the Brazilian Association of Organ Transplantation (ABTO), where he created the Brazilian Transplant Registry and helped shape the foundations of Brazil’s current organ procurement and allocation system. A founding member of the International Pediatric Transplant Association, he has also held important editorial and leadership roles in international transplantation and nephrology. He has published 174 studies in indexed international journals.

Oscar Imventarza was born and grew up in Buenos Aires Argentina. He graduated from the University of Buenos Aires (UBA) in 1982. He received his surgical training between 1983-1986 at the Hospital Argerich and the Hospital Finochietto.
In 1987 he began his training in Hepatobiliary Surgery and Liver Transplantation at the Transplant Division of the University of Pittsburgh under the supervision of Professor Thomas Starzl. He became Research fellow (1987), Clinical Fellow (1988), Instructor of Surgery (1989) and Assistant Professor of the same University in 1990.
Oscar Imventarza returned to Argentina at the end of 1992 and opened as Chairman the first two Public Liver Transplant Programs of Argentina in the Hospital Juan P Garrahan (children's) and Hospital Dr C Argerich (adult's). Both became the most important public HPB centers of Argentina. Also he developed the first Liver and Pancreas Transplant Program of the Litoral Region located in Formosa City.
Professor Imventarza has been an active member of different surgical societies. He was a founding member and President of the Argentine Society of Transplantation, Council Member of the Argentine Chapter of the IHPBA (CA-IHPBA) since 2007 and President of the same Chapter for 2013-2015 period. He is an Active Member of the Argentine Academy of Surgery. His practice is focused in liver surgery and transplantation for adult and pediatric patients.

Dr. Lori West is a Professor of Pediatrics, Surgery, Medical Microbiology/Immunology and Laboratory Medicine/Pathology at the University of Alberta. A clinician-scientist, Dr. West has longstanding interest and expertise in pediatric heart transplantation and transplant immunology, with a focus on immune tolerance. Her pioneering work on crossing ABO barriers led to global advancement in infant heart transplantation, and she continues in-depth exploration of ABO-glycoimmunology related to organ transplantation and the impact of ABO-histocompatibility on international transplantation and organ allocation practices and policies.
Dr. West is the past-President of the International Society of Heart and Lung Transplantation and the Canadian Society of Transplantation, past-Chair of the Women in Transplantation international initiative of The Transplantation Society, served as a member of the Board of Directors of the American Society of Transplantation, and is a British Society of Transplantation honorary lifetime member. She directed the Alberta Transplant Institute from 2013 to 2024. With Dr. Marie-Josée Hébert, Dr. West co-founded the Canadian Donation and Transplantation Research Program, a national research coalition funded by the government of Canada in 2013 and encompassing collaborations across all streams of research, with 300+ current investigators at 40+ sites across Canada and internationally. A Fellow of both the Royal Society of Canada and the Canadian Academy of Health Sciences, Dr. West was inducted as an Officer of the Order of Canada in 2022. She received the Lifetime Achievement Award from the Canadian Society of Transplantation, the 2023 Physician of Distinction Award from the American Society of Transplantation, and the 2024 Lifetime Achievement Award from the International Society of Heart and Lung Transplantation. Dr. West was awarded the King Charles III Coronation Medal in 2025.
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada
Используйте Вавада казино для игры с бонусом — активируйте промокод и начните выигрывать уже сегодня!